K181373 is an FDA 510(k) clearance for the Extended Lipid Panel Assay. Classified as Enzymatic Esterase--oxidase, Cholesterol (product code CHH), Class I - General Controls.
Submitted by Laboratory Corporation of America Holdings (Morrisville, US). The FDA issued a Cleared decision on October 18, 2018 after a review of 147 days - within the typical 510(k) review window.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1175 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.